Movicol Paediatric Plain

Macrogol 3350, the active ingredient in Movicol Paediatric Plain, is an osmotic laxative presented as an oral powder for suspension for oral use. It is used to relieve constipation in children by increasing water content in the intestinal lumen. GNH USA supplies Movicol Paediatric Plain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Paediatric Plain is an osmotic laxative indicated for the management of constipation in the paediatric population. - Constipation: softens stools and promotes regular bowel movements in children with functional constipation.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas. - Nausea: mild feeling of sickness. - Diarrhoea: loose, watery stools. - Thirst: increased desire to drink fluids. - Abdominal discomfort: mild cramps or pain.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal levels of sodium, potassium, or chloride. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: intense or persistent pain. - Rectal bleeding: blood in stool or on toilet paper.

Before using Movicol Paediatric Plain, consider the following precautions. - Hydration status: ensure adequate fluid intake to prevent dehydration. - Electrolyte monitoring: check serum electrolytes in children with renal or cardiac disease. - Renal impairment: use under medical supervision if kidney function is compromised. - Bowel obstruction: avoid if there is a known mechanical blockage. - Dose adjustment: may be required for severe constipation or in very young children. - Store at below 25°C: keep in the original pack, protect from moisture.

Movicol Paediatric Plain may interact with other medicines. Major Interactions (Avoid): - Other osmotic laxatives: risk of excessive fluid loss and electrolyte disturbance. - Loop diuretics: may exacerbate electrolyte imbalance. - Lithium: increased risk of lithium toxicity due to altered renal clearance.

Moderate Interactions (Monitor Closely): - NSAIDs: potential impact on renal function, especially in dehydrated children. - ACE inhibitors: monitor blood pressure and electrolytes. - Calcium supplements: may affect electrolyte balance.